InsidersTradesSigma
Browse the detailed record of transactions filed by Broder Samuel, Director. Director active across 1 companies, notably Sensei Biotherapeutics, Inc.. Aggregated, 1 reports have been logged. The latest transaction was disclosed on 10 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration
Samuel Broder is a Board Member at Sensei Biotherapeutics, Inc. He plays a key role in the strategic direction of the company, contributing to policy development and operational oversight. His expertise in the biopharmaceutical field is essential in guiding the organization's innovation and growth.